Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Franco Gadda is active.

Publication


Featured researches published by Franco Gadda.


Clinical Genitourinary Cancer | 2013

Long-Term Follow-Up Using Testicle-Sparing Surgery for Leydig Cell Tumor

Giorgio Bozzini; Stefano Picozzi; Franco Gadda; Renzo Colombo; Ottavio DeCobelli; Jean Palou; GiovanniMaria Colpi; Luca Carmignani

BACKGROUND Our objective was to perform a long-term evaluation of conservative surgical treatment of Leydig cell tumors. PATIENTS AND METHODS A multicenter retrospective clinical study was performed at 6 European centers. Case files of all patients diagnosed with Leydig cell tumor and treated with conservative surgery were examined. Patients underwent physical examination, hormone and tumor marker assays, scrotal and abdominal ultrasonography, chest radiography, and endocrinologic examination. RESULTS From 1987 to 2006, 22 patients with Leydig cell tumor underwent conservative surgery. Mean patient age was 35 years (range, 5-61 years). Mean follow-up was 180 months (range, 77-290 months). No local recurrence or metastasis was observed. Patients presented with a palpable testicular nodule (3 patients [13.7%]), a nodule diagnosed by ultrasonography (15 patients [68.2%]), gynecomastia (2 patients [9.1%]), precocious pseudopuberty (1 patient [4.5%]), or scrotal pain (1 patient [4.5%]). Diagnosis after frozen section examination was Leydig cell tumor in 20 of 22 patients (91%). Mean histologic size of the nodule was 1.11 cm. Follow-up was conducted for all patients every 3 to 6 months, with physical examination, tumor marker assays, scrotal and abdominal ultrasonography, chest radiography, and computed tomography (CT). No local recurrences or metastases were observed. One hundred percent of patients are still alive with a 100% disease-free survival. CONCLUSIONS When diagnosed and treated early, long-term favorable outcomes are seen at follow-up in Leydig cell tumors, even with its potential metastatic behavior. In these patients, testicle-sparing surgery proved to be a feasible and safe choice and could be regarded as the first line of therapy.


BJUI | 2005

Testicular-sparing microsurgery for suspected testicular masses

Giovanni M. Colpi; Luca Carmignani; Franco Nerva; Piediferro Guido; Franco Gadda; Fabrizio Castiglioni

To describe a microsurgical technique for removing suspected testicular masses with sparing of the testicular parenchyma, and to describe case studies.


Scandinavian Journal of Urology and Nephrology | 2013

Perineural invasion as a predictor of extraprostatic extension of prostate cancer: a systematic review and meta-analysis.

Gabriele Cozzi; Bernardo Rocco; Angelica Grasso; Marco Rosso; Davide Abed El Rahman; Isabella Oliva; Michele Talso; Beatrice Costa; Ardit Tafa; Carlotta Palumbo; Franco Gadda; Francesco Rocco

Abstract A systematic review of the literature was performed to assess the relationship between the presence of perineural invasion (PNI) at prostate biopsy and extraprostatic extension (EPE) of prostate cancer. In August 2012, Medline, Embase, Scopus and Web of Science databases were searched. A “free-text” protocol using the terms “perineural invasion prostate cancer” was applied. Studies published only as abstracts and reports from meetings were not included in this review. In total, 341 records were retrieved from Medline, 507 from Embase, 374 from Scopus and 65 from the Web of Science database. The records were reviewed to identify studies correlating the presence of PNI with that of EPE. A cumulative analysis was conducted using Review Manager software v. 5.1 (Cochrane Collaboration, Oxford, UK). In univariate analysis, PNI showed a statistically significant association with pT3 tumours (p < 0.00001), which could be observed for both pT3a (p < 0.0001) and pT3b (p < 0.0001). In conclusion, the cumulative analysis shows a statistically significant higher incidence of EPE in patients who had PNI at needle biopsy. The main limitation of the analysis was that it was not possible to perform a multivariate analysis. Further attempts to build a nomogram for the prediction of EPE could include the presence of PNI at needle biopsy.


Ecancermedicalscience | 2013

Robotics in uro-oncologic surgery.

Elisa De Lorenzis; Carlotta Palumbo; Gabriele Cozzi; Michele Talso; Marco Rosso; Beatrice Costa; Franco Gadda; Bernardo Rocco

In urology, the main use for the robotic technique has been in radical prostatectomy for prostate cancer. Robotic surgery for other organs, such as the kidneys and bladder, has been less explored. However, partial nephrectomy or radical nephroureterectomy can be difficult for inexperienced laparoscopic surgeons. The advent of the da Vinci robot, with multijointed endowristed instruments and stereoscopic vision, decreases the technical difficulty of intracorporeal suturing and improves the reconstructive steps. The objective of this article is to offer an overview of all robotic procedures recently developed in the field of urology. We evaluate the feasibility of these procedures and their potential advantages and disadvantages. We also describe perioperative, postoperative, and oncologic outcomes of robot-assisted surgery as well as perform a comparison with open and laparoscopic techniques. Comparative data and an adequate follow-up are needed to demonstrate equivalent oncologic outcomes in comparison with traditional open or laparoscopic procedures.


European Urology | 2013

Antiplatelet Therapy in Patients With Coronary Stent Undergoing Urologic Surgery: Is It Still No Man's Land?

Richard Naspro; Roberta Rossini; Giuseppe Musumeci; Franco Gadda; Luigi Da Pozzo

Percutaneous coronary intervention (PCI) in patients with coronary artery disease is increasing worldwide. Every year more than one million PCIs are performed in the United States and Europe (Roger et al. 2011; Moschovitis et al. 2010). In more than 85 % of cases, a coronary stent is implanted (Savonitto et al. 2011), and prolonged antiplatelet therapy is mandatory after stent implantation. International guidelines recommend dual antiplatelet therapy (DAPT) for at least 4 weeks after bare metal stent (BMS) and 6–12 weeks after drug-eluting stent (DES) implantation (Task Force on Myocardial Revascularization of the ESC 2010). Premature withdrawal of antiplatelet therapy is associated with a significantly higher risk of cardiac ischemic events, due to stent thrombosis (ST). This is a rare but life-threatening complication, which occurs most of the time as acute myocardial infarction with a mortality of 10–40 %. Stent thrombosis is up to 90 times higher after premature discontinuation of DAPT (Iakovou et al. 2005). The prevalence and causes of premature discontinuation of DAPT after DES implantation have been assessed in previous studies, showing that premature discontinuation was not a rare event (more than one patient out of ten). The most common causes of discontinuation were surgery and bleeding events and were often associated with a poor prognosis (Rossini et al. 2011; Ferreira-Gonzalez et al. 2010).


Radiologia Medica | 2016

MRI of penile fracture: what should be a tailored protocol in emergency?

A. Esposito; Caterina Giannitto; Claudia Muzzupappa; Sara Maccagnoni; Franco Gadda; Giancarlo Albo; Pietro Biondetti

ObjectivesTo conduct a review of literature to summarize the existing MRI protocols for penile trauma, suggesting a tailored protocol to reduce costs and time of examination.Materials and methodsA systematic search was performed in Medline, Embase, Cochrane Library, and Cinahl databases from 1995 to 2015 to identify studies evaluating penis trauma with MRI examination. Studies were included if there was the description of MRI protocol with at least sequences and orthogonal planes used. We chose a systematic approach for data extraction and descriptive synthesis.Results12 articles were included in our study. Among the list of 12 articles: 2 were case reports, 3 were clinical series, and 7 were reviews. Clinical trials were not found. There is no unanimous consensus among the authors. Summarizing the data, the most used protocol is characterized by T2 sequences in three orthogonal planes plus T1 sequences in one plane (either axial or sagittal) without contrast medium injection.ConclusionThere is a lack of a standard protocol. A tailored protocol to answer the diagnostic question, reducing costs and time of examination, is characterized by T2 sequences in three orthogonal planes plus at least a T1 sequence (either axial or sagittal plane).


Journal of Cellular Biochemistry | 2018

Suppressive effects of tenofovir disoproxil fumarate, an antiretroviral prodrug, on mineralization and type II and type III sodium-dependent phosphate transporters expression in primary human osteoblasts

Anna Maria Barbieri; Iacopo Chiodini; Enrico Ragni; Graziana Colaianni; Franco Gadda; Marco Locatelli; P. Lampertico; Anna Spada; Cristina Eller-Vainicher

Tenofovir disoproxil fumarate (TDF) is an antiretroviral drug commonly used for the management of Human Immunodeficiency Virus (HIV) in highly active antiretroviral therapy (HAART) and of chronic Hepatitis B Virus (HBV) infections. Long‐term TDF‐treated subjects present decrease of bone mineral density and rarely severe osteomalacia. Although these adverse effects have been attributed to the impaired proximal tubule function, a possible direct involvement of TDF on osteoblasts should be taken into account. The aim of this study was to evaluate whether sodium phosphate transporters NPT2A (sodium‐dependent phosphate transport protein 2A), NPT2C (sodium‐dependent phosphate transport protein 2C), PIT1 (sodium‐dependent phosphate transporter 1), and PIT2 (sodium‐dependent phosphate transporter 2) were expressed in primary human osteoblasts (HOBs), whether their expression was related to HOBs differentiation and whether TDF could affect mineralization and gene expression. PIT1 and PIT2 were expressed under proliferating conditions and increased after induction of mineralization, while NPT2A and NPT2C were almost undetectable. In HOBs TDF exposure induced a significant dose‐dependent decrease in mineralization. Moreover, TDF caused a reduction of COL1A1 and of ATF4 expression in differentiated HOBs. In summary, HOBs do not express NPT2A and NPT2C and do express PIT1 and PIT2, suggesting a role of these two latter in human osteoblast mineralization. TDF impairs osteoblast mineralization, confirming a direct negative effect on bone. Therefore, in clinical practice, bone damage must be suspected and evaluated also in patients receiving TDF without kidney function alterations.


Sexually Transmitted Diseases | 2015

Rapidly Invasive Buschke-Löwenstein Tumor Associated With Human Papillomavirus Types 6 and 52.

Marco Diani; Vinicio Boneschi; Stefano Ramoni; Franco Gadda; Alessandro Del Gobbo; Marco Cusini

Buschke-Löwenstein tumor, or giant condyloma acuminatum, represents a rare, sexually transmitted disorder, with a slow evolution and the tendency to infiltrate in the adjacent tissues associated with human papillomavirus (HPV). This article reports the first case of male Buschke-Löwenstein tumor associated with HPV6 and HPV52.


Urology case reports | 2018

Glans penis necrosis following paraphimosis: A rare case with brief literature review

F. Palmisano; Franco Gadda; Matteo Giulio Spinelli; E. Montanari

A 83-year-old man presented to the urology department with a painful swelling of the glans penis. The patient was admitted from the emergency department for pneumonia and urinary tract infection two days before, and a urethral catheter was placed. Physical examination showed preputial edema and a swollen glans penis associated with an ischemia-related hemorrhagic mucosal suffusion (Fig. 1). A diagnosis of glans penis necrosis caused by paraphimosis was made.


Urologia Internationalis | 2018

Medical Expulsive Therapy for Symptomatic Distal Ureter Stones: Is the Combination of Bromelain and Tamsulosin More Effective than Tamsulosin Alone? Preliminary Results of a Single-Center Study

F. Palmisano; Matteo Giulio Spinelli; Stefano Luzzago; Luca Boeri; Elisa De Lorenzis; Giancarlo Albo; Franco Gadda; M. Gelosa; Fabrizio Longo; Paolo Guido Dell’Orto; E. Montanari

Objectives: To assess the safety and efficacy of bromelain plus tamsulosin versus tamsulosin alone as medical expulsive therapy (MET) for promoting spontaneous stone passage (SSP) of symptomatic distal ureter stones. Patients and Methods: One-hundred-fourteen patients with a 4–10 mm distal ureteral stone were enrolled (Group A). Patients self-administered daily bromelain with tamsulosin for 30 days or until SSP or intervention was mandatory. Patients were compared to those from a control group taking tamsulosin as MET (Group B) and matched for the following factors: sex, age ±10%, stone diameter. A logistic regression model evaluated bromelain and the ureteral stone diameter as explanatory variables. Results: SSP rates were 87.7 vs. 75.4% for group A vs. group B respectively (p = 0.016); with no difference observed for the time to self-reported stone expulsion (11.68 vs. 11.57 days; p = 0.91). Considering larger stones (> 5 mm), the SSP rate was 83.3% in group A and 61% in group B (p < 0.01). With each millimeter increment of stone diameter, the probability of SSP decreased by 59.1% (p < 0.0001), while it increased of 3.3 when bromelain was present. Only 3 cases of tamsulosin-related adverse events were recorded. Conclusion: The association of bromelain and tamsulosin as MET increases the probability of SSP of symptomatic distal ureteral stones, with no bromelain-related side effects recorded.

Collaboration


Dive into the Franco Gadda's collaboration.

Top Co-Authors

Avatar

Francesco Rocco

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

E. Montanari

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

View shared research outputs
Top Co-Authors

Avatar

Matteo Giulio Spinelli

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Bernardo Rocco

University of Modena and Reggio Emilia

View shared research outputs
Researchain Logo
Decentralizing Knowledge